Peptilogics
Dr. Pachuda has over three decades of experience in orthopedics and a strong track record in transitioning businesses from early product development through commercialization. Most recently, he served as the Worldwide Vice President of External Innovation and Enabling Technologies for DePuy Synthes, the Orthopedic Franchise at Johnson & Johnson, where he led a global team to deliver high value external assets to the DePuy Synthes portfolio. Prior to this, Dr. Pachuda served in various senior leadership roles in marketing, business development, and clinical strategy at DePuy Synthes, Arthrex, Scient'x, and Small Bone Innovations. Dr. Pachuda is a University of Pittsburgh graduate and holds a Doctorate of Podiatric Medicine from the Pennsylvania College of Podiatric Medicine. He also completed an AO Orthopedic Trauma Fellowship.
This person is not in any offices
Peptilogics
Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.